Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5101
CALL
Equity Residential
EQR
$24.9B
| $162K | ﹤0.01% |
2,000
+1,900
| +1,900% | +$162K |
|
|
FARM
5102
DELISTED
Farmer Brothers
FARM
| $162K | ﹤0.01% |
10,789
+5,419
| +101% | +$79.1K |
|
5103
Target Hospitality
TH
$1.51B
| $162K | ﹤0.01% |
32,558
-10,057
| -24% | -$52.9K |
|
5104
eGain
EGAN
$187M
| $161K | ﹤0.01% |
20,374
+9,986
| +96% | +$77.2K |
|
5105
CALL
Community Health Systems
CYH
$393M
| $160K | ﹤0.01% |
55,000
+40,100
| +269% | +$139K |
|
5106
PUT
Lazard
LAZ
$4.13B
| $160K | ﹤0.01% |
4,000
-5,600
| -58% | -$212K |
|
5107
Aclaris Therapeutics
ACRS
$726M
| $159K | ﹤0.01% |
83,853
+66,735
| +390% | +$111K |
|
5108
CALL
Radian Group
RDN
$5.18B
| $159K | ﹤0.01% |
6,300
+6,100
| +3,050% | +$152K |
|
|
ZEUS
5109
PUT
DELISTED
Olympic Steel
ZEUS
| $159K | ﹤0.01% |
8,900
| – | – |
|
5110
PUT
Camping World
CWH
$639M
| $158K | ﹤0.01% |
10,700
-6,900
| -39% | -$78.1K |
|
5111
Endava
DAVA
$158M
| $158K | ﹤0.01% |
3,400
-15,046
| -82% | -$649K |
|
5112
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.34B
| $158K | ﹤0.01% |
2,117
+278
| +15% | +$20.7K |
|
5113
Noodles & Co
NDLS
$111M
| $158K | ﹤0.01% |
3,569
+1,295
| +57% | +$57.2K |
|
|
MNK
5114
CALL
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $158K | ﹤0.01% |
45,400
-7,000
| -13% | -$21.8K |
|
5115
CALL
Direxion Daily Energy Bear 2X ETF
ERY
$39.1M
| $157K | ﹤0.01% |
400
-570
| -59% | -$266K |
|
|
GREK
5116
Global X MSCI Greece ETF
GREK
$300M
| $157K | ﹤0.01% |
5,146
+3,432
| +200% | +$100K |
|
5117
Stagwell
STGW
$2.07B
| $157K | ﹤0.01% |
56,582
+28,694
| +103% | +$77.3K |
|
5118
Algonquin Power & Utilities
AQN
$4.49B
| $156K | ﹤0.01% |
10,997
-29,841
| -73% | -$414K |
|
5119
AudioCodes
AUDC
$244M
| $156K | ﹤0.01% |
6,085
+5,676
| +1,388% | +$124K |
|
|
CASI
5120
DELISTED
CASI Pharmaceuticals
CASI
| $156K | ﹤0.01% |
5,043
+2,557
| +103% | +$82.9K |
|
5121
Clearfield
CLFD
$411M
| $156K | ﹤0.01% |
11,208
+5,639
| +101% | +$72.9K |
|
5122
CALL
ProShares Ultra Dow30
DDM
$542M
| $156K | ﹤0.01% |
5,600
+4,800
| +600% | +$125K |
|
5123
Donegal Group Class A
DGICA
$731M
| $156K | ﹤0.01% |
10,523
+5,153
| +96% | +$75.4K |
|
5124
Savara
SVRA
$1.12B
| $156K | ﹤0.01% |
34,966
+17,079
| +95% | +$20.6K |
|
|
TREC
5125
DELISTED
Trecora Resources
TREC
| $156K | ﹤0.01% |
21,760
+10,899
| +100% | +$89.1K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.